Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.

Common pollutants are disrupting energy production at the cellular level in wild seabirds, potentially affecting fitness, new ...

Reliance Industries pauses its plans to manufacture lithium-ion cells in India amid challenges in securing technology ...

Reliance Industries Ltd. has halted its plans to manufacture lithium-ion battery cells in India due to the inability to ...

Cellares, the contract drugmaker known for its cell therapy factory-in-a-box, will expand its operations to Europe after ...

Gujarat is leading India's solar cell manufacturing with significant investments and capacity expansions, positioning itself ...

Reliance Industries has denied reports of pausing its lithium-ion battery cell manufacturing plans, saying work on its ...

India’s Reliance Industries said on Monday that its plans for battery storage manufacturing remain unchanged, following a ...

FDA Commissioner Marty Makary called these changes “common-sense reforms” that could expedite the development of cell and ...

CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

For the last two years, the cultivated meat industry has been experiencing growing pains. Many startups have shrunk, shut ...